Effect of long-term cholesterol-lowering treatment with HMG-CoA reductase inhibitor (simvastatin) on myocardial perfusion evaluated by thallium-201 single photon emission computed tomography

Japanese Circulation Journal

Volumn 64, Issue 3, 2000, Pages 177-182

  Hosokawa, Ryohei ^a   Nohara, Ryuji ^a   Linxue, Li ^a   Tamaki, Shunichi ^a   Hashimoto, Tetsuo ^a   Tanaka, Masahiro ^a   Miki, Shinji ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholesterol; HDL cholesterol; HMG CoA reductase inhibitor (simvastatin); Myocardial perfusion

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; SIMVASTATIN; THALLIUM 201;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; EXERCISE; FEMALE; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; MALE; MULTICENTER STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ANGINA PECTORIS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; SIMVASTATIN; THALLIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034108180     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.64.177     Document Type: Article

References (31)

1. Scandinavian Simvastatin Survival Study Investigators: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389
2. Byington RP, Jukema JW, Salonen JT, Pitt B, Bruschke AV, Hoen H, et al: Reduction in cardiovascular events during pravastatin therapy. Circulation 1995; 92: 2419-2425
3. Shepherd J, Cobbe S, Ford I, Isles CG, Lorimar AR, MacFarlane P, et al: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study. N Engl J Med 1995; 333: 1301-1307
4. Brown BC, Shao XQ, Sacco DE, Albers JJ: Lipid-lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993; 87: 1781-1791
5. Brown G, Albers JJ, Fisher L, Schaefer SM, Lin JT, Kaplan C, et al: Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289-1298
6. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inoue T, et al: Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hyper-cholesterolemia. Circulation 1994; 89: 2519-2524
7. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stullabower ME, Kosinski AS, et al: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-487
8. Anderson TJ, Meredith IT, Young AC, Frei B, Selwyn AP, Ganz P: The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488-493
9. Leung WH, Lau CP, Wong CK: Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1989; 341: 1496-1500
10. Stroes ES, Koomans HA, de Bruin TW, Rabelink TJ: Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1993; 346: 467-471
11. O'Driscoll G, Green D, Taylor RR: Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95: 1126-1131
12. Armstrong ML, Mogan MB: Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets. Circ Res 1972; 30: 675-680
13. Kaplan JR, Manuck SB, Adams MR, Williams JK, Register TC, Clarkson TB: Plaque changes and arterial enlargement in atherosclerotic monkeys after manipulation of diet and social environment. Arterioscler Thromb 1993; 13: 254-263
14. Heistad DD, Armstrong ML: Sick vessel syndrome. Can atherosclerotic arteries recover? (Editorial). Circulation 1998; 89: 2447-2450
15. Corsini A, Raiteri M, Soma M, Fumagalli R, Paoletti R: Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes. Pharmacol Res 1991; 23: 173-180
16. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, et al: Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333: 621-627
17. Lacoste L, Lam J, Hung J, Letchacovski G, Solymoss C, Waters D: Hyperlipidemia and coronary disease: correction of the increased thrombogenic potential with cholesterol reduction. Circulation 1995; 92: 3172-3177
18. Green DJ, O'Driscoll JG, Blanksby BA, Taylor RR: Lack of effect of vitamin E administration on basal nitric oxide function in male smokers and non-smokers. Clin Sci 1995; 89: 343-348
19. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D: Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995; 25: 918-931
20. Egashira K, Inoue T, Yamada A, Hirooka Y, Maruoka Y, Takeshita A: Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 1990; 91: 29-37
21. Yokoyama I: Improvement of coronary flow reserve in hyperlipidemics in angiographically normal coronary arteries after lipid-lowering therapy (abstract). J Nucl Med 1997; 38: 85
22. Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edeus RP, Latific R, et al: Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. Circulation 1994; 89: 1530-1538
23. Buda AJ: Spontaneous changes in the T1-201 myocardial perfusion imaging after myocardial infarction. Am J Cardiol 1982; 50: 1272-1275
24. Hasdai D, Gibbons RJ, Holmes DR, Higano ST, Lerman A: Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997; 96: 3390-3395
25. Bakker A, Thone F, Borgers M, Jacob W: Contact sites between the inner and outer mitochondrial membranes in stunned versus hibernating myocardium. Cardiovasc Pathol 1995; 4: 195-202
26. Chiariello M, Perrone-Filardi P, Ambrosio G: Hibernating and stunned myocardium. Cardioscience 1993; 4: 63-68
27. Elsasser A, Schlepper M, Klorekorn WP, Cai W, Zimmermann R, Muller KD, et al: Hibernating myocardium -An incomplete adaptation to ischemia. Circulation 1997; 96: 2920-2931
28. Tamaki N, Kawamoto M, Takahashi N, Yonekura Y, Magata Y, Nohara R, et al: Prognostic value of an increase in F-18-FDG uptake in patients with MI. Comparison with stress T1-201. J Am Coll Cardiol 1993; 22: 1621-1627
29. Hump J, Goris ML, Nash E, Kracmer HC: Comparative value of maximal treadmill exercise testing, exercise thallium myocardial perfusion scintigraphy, and exercise radionuclide ventriculography for distinguishing high- and low-risk patients after acute MI. Am J Cardiol 1984; 53: 1221-1227
30. Frost PH, Dawiz BR, Brulands AJ, Curb JD, Gorthrie GP, Isqacsoha JL, et al: Findings from the systolic hypertension in the elderly prepair (SHEP). Circulation 1996; 94: 2381-2388
31. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 23: 3015-3023